Novo Nordisk and Gilead team up to test fatty liver disease treatment
Novo Nordisk and Gilead Sciences will join forces on a clinical trial combining drugs from the two pharmaceutical firms to treat a progressive fatty liver disease known as NASH.
from Reuters: Health News https://reut.rs/2X7oQA6
http://bit.ly/2zwRqiM